local_hospital

Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara

Address
lock Available on a paid plan

Paediatrics-Neurology at Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara

This site is conducting clinical research in paediatrics and neurology, with a focus on epilepsy. The work is aimed at understanding the long-term use of treatments that may help manage seizures more effectively in children and adolescents.

  • Studying epilepsy in pediatric patients
  • Evaluating the long-term safety and usefulness of a treatment for seizure control

The research at this hospital supports better care for children living with neurological conditions and helps build evidence for treatment options used over time.

Hemic and Lymphatic Diseases research in Timisoara

Another key area at the site is haematology, especially anemia associated with chronic kidney disease. These trials are exploring whether a new therapy can improve blood-related outcomes in children and adolescents affected by kidney disease.

  • Focusing on anemia in pediatric patients with chronic kidney disease
  • Assessing a treatment intended to improve the management of hemic and lymphatic diseases

This line of research helps evaluate treatment effectiveness in a vulnerable paediatric population and may support more personalized care for young patients with complex chronic conditions.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
2
Outperforms 37% of sites
public
Therapeutic diversity
2areas
Outperforms 51% of sites
groups
Sponsor diversity
2sponsors
Outperforms 42% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Spitalul Clinic De Urgenta Pentru Copii Louis Turcanu Timisoara

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter, Open-Label, Follow-Up Study to Assess the Long-Term Use of Oral Lacosamide in Study Participants Who Completed EP0034 or SP848 and Received Lacosamide TreatmentUCB BiopharmaPhase IIINot RecruitingDec 2020Feb 2025

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Epoetin Alfa1Unknown2023-12-212023-12-21

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.